Languages SpokenEnglish Common ConditionsBased on the training and education, Dr. Avery Lachance, MD, MPH may treat patients with the following conditions. Please always check with Dr. Avery Lachance, MD, MPH directly about which exact conditions she treats. - Liver Spots
- Hyperpigmentation
- Skin Redness
- Razor Bumps
- Unwanted Tattoos
- Flabby Arms
- Frizzy Hair
- Hypersensitive Skin
- Thin Lips
- Oily Skin
- Spider Veins
- Crow's Feet
- Turkey Neck
- Forehead Wrinkles
- Keratosis Pilaris
- Dandruff
- Small Breasts
- Puffy Eyes (Eye Bags)
- Sparse Eyebrows (Thin Eyebrows)
- Psoriasis
Prescribed MedicationsClindamycin Calcipotriene Betamethasone Dipropionate Taltz Autoinjector (Generic Name: ixekizumab) Octagam (Generic Name: immun globg(igg)/malt/iga ov50) Prednisone Spironolactone Mycophenolate Mofetil Tretinoin Mupirocin TreatmentsBased on the training and education, Dr. Avery Lachance, MD, MPH may perform the following treatments. Please always check with Dr. Avery Lachance, MD, MPH directly about which exact treatments he offers. - Liquid Facelift
- Juvederm
- Thermage
- Non-Surgical Nose Job
- Radiesse
Research & PublicationsApproximately 55% of Dermatologists in Boston, MA have available research publications A geospatial analysis of the association between the period prevalence of sarcoidosis and environmental toxins in Massachusetts. Emmanuella N Asabor, Bina Kassamali, Kylee J B Kus, Nidhi Shah, Jacqueline Maher, Camila Villa-Ruiz, Ali Asghar Kassamali, Kevin Yang, Ruth Ann Vleugels, Avery H LaChance, Sotonye Imadojemu The British journal of dermatology 2026-01-27 Patient triage for new appointments in medical dermatology may help decrease long waits for urgent and high-risk conditions: A multivariate retrospective analysis of factors associated with appointment lead times. Grant J Riew, David Xiang, Baraa Hijaz, Joseph Michael Yardman-Frank, Gideon P Smith, Avery H LaChance, Vinod E Nambudiri, John Trinidad Journal of the American Academy of Dermatology 2026-01-07 Public perceptions on the medical versus cosmetic nature of dermatologic conditions. Aliya Shabbir, Avery H LaChance, John S Barbieri Journal of the American Academy of Dermatology 2025-11-10 Rituximab versus mycophenolate mofetil for cancer risk in systemic sclerosis. Arjun Mahajan, Evan W Piette, Jeffrey A Sparks, Avery H LaChance Rheumatology (Oxford, England) 2025-11-01 Autoantibody testing practices and clinical implications in morphea: A 5-year multicenter retrospective study. Maria Vazquez-Machado, Nikki Zangenah, Lorena A Acevedo-Fontanez, Ellen Anshelevich, Rachael Rowley, William Crisler, Avery H LaChance Journal of the American Academy of Dermatology 2025-09-26 Rituximab vs cyclophosphamide for cancer risk in ANCA-associated vasculitis. Arjun Mahajan, Martin Viola, Jacob Ellen, Evan W Piette, Avery H LaChance, Jeffrey A Sparks Rheumatology (Oxford, England) 2025-08-01 Eosinophilic Fasciitis and Morphea Share Gene Signatures of Inflammatory Cell Death, Self-DNA Recognition, and Enhanced Jak/Signal Transducer and Activator of Transcription Signaling. William J Crisler, Rachael Rowley, Oluwadamilola Oke, Samuel J Steuart, Maitri M Modi, Dale L Davis, Cynthia Chen, Lindsey Gray, Jessica E Teague, Qian Zhan, Joseph F Merola, Ruth Ann Vleugels, Rachael A Clark, Avery LaChance The Journal of investigative dermatology 2025-05-30 Response to Hewitt et al, "Overlap of generalized morphea and eosinophilic fasciitis after recreational exposure to epoxy resin". Daniel R Mazori, Kristen I Lo Sicco, Avery H LaChance, Ruth Ann Vleugels, Alisa N Femia JAAD case reports 2025-05-24 Improvement in dermatomyositis-associated muscle disease with anifrolumab. Leila H Shayegan, Katharina S Shaw, Ged G Wieschhoff, Nnenna Ezeh, Yoo Jung Kim, Neda Shahriari, Ellen E Anshelevich, Lorena A Acevedo, Avery LaChance, Fatma Dedeoglu, Rochelle L Castillo, Allen W Ho, Ruth Ann Vleugels The British journal of dermatology 2025-05-19 Janus kinase inhibitor adverse event profiles in dermatology patients: the experience of two academic medical centres. Subin Lim, Oluwadamilola H Oke, Kaitlynne N Cunningham, Courtney Chau, Lillian Sidky, Bridget Cange, Avery H LaChance, Gabriela A Cobos Clinical and experimental dermatology 2025-04-24 Payments From Medical Companies(These can include payments from pharmaceutical companies, medical device companies, and other companies.) Dr. Avery Lachance, MD, MPH has received over $10,828 in payments from medical companies (62% less than the average Dermatologist in Boston, MA) - Over $8,845 in payments for Consulting Fee (30% less than the average Dermatologist in Boston, MA)
- Over $1,561 in payments for Travel and Lodging (29% less than the average Dermatologist in Boston, MA)
- Over $367 in payments for Food and Beverage (73% less than the average Dermatologist in Boston, MA)
- Over $54 in payments for Education (42% less than the average Dermatologist in Boston, MA)
Janssen Biotech, Inc. - $164.86 payment for Travel and Lodging on 07/27/2024 Janssen Biotech, Inc. - $7,425.00 payment for Consulting Fee on 07/27/2024 Janssen Biotech, Inc. - $6.12 payment for Food and Beverage on 07/27/2024 Janssen Biotech, Inc. - $19.97 payment for Food and Beverage on 07/12/2024 Janssen Biotech, Inc. - $39.73 payment for Food and Beverage on 07/12/2024 Janssen Biotech, Inc. - $49.87 payment for Food and Beverage on 07/12/2024 Janssen Biotech, Inc. - $216.64 payment for Travel and Lodging on 07/11/2024 Janssen Biotech, Inc. - $830.24 payment for Travel and Lodging on 07/11/2024 Janssen Biotech, Inc. - $124.52 payment for Food and Beverage on 07/11/2024 Janssen Biotech, Inc. - $349.28 payment for Travel and Lodging on 07/11/2024
Affiliated FacilitiesNewton-wellesley Hospital Brigham and Women's Hospital Brigham and Women's Faulkner Hospital
|